Medication program persistence and engagement: January 2026 analysis of 30,239 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025, evaluating program persistence by engagement quartile
If you have questions about B12 supplementationwhether concerned about deficiency or excessyour GP or a registered dietitian can provide personalised, evidence-based guidance tailored to your individual circumstances and health status
Mary Colman has over 24 years of experience in integrative metabolic care and whole-food supplementation using Standard Process products
has also served on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Menarini/Berlin-Chemie, Merck, Sharp & Dohme, NovoNordisk and Sun Pharma
Lower inflammation and better physical function may allow disease-modifying therapies to work more effectively, even though this has not yet been directly proven in adults, she says
"Two Things Most Reviews Skip" is an editorial description of those same two documented gaps, not a universal claim about every review that exists